Title: CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial
Authors: Alexandre, J ×
Brown, C
Coeffic, D
Raban, N
Pfisterer, J
Mäenpää, J
Chalchal, H
Fitzharris, B
Volgger, B
Vergote, Ignace
Pisano, C
Ferrero, A
Pujade-Lauraine, E #
Issue Date: Feb-2012
Publisher: Harcourt Publishers
Series Title: British Journal of Cancer vol:106 issue:4 pages:633-7
Article number: 10.1038/bjc.2011.593
Abstract: CA-125 as a tumour progression criterion in relapsing ovarian cancer (ROC) trials remains controversial. CALYPSO is a large randomised trial incorporating CA-125 (GCIG criteria) and symptomatic deterioration in addition to Response Evaluation Criteria in Solid Tumours (RECIST) criteria (radiological) to determine progression.
ISSN: 0007-0920
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Gynaecological Oncology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science